Gene: GPRC5B
Official Full Name: G protein-coupled receptor class C group 5 member Bprovided by HGNC
Gene Summary: This gene encodes a member of the type 3 G protein-coupled receptor family. Members of this superfamily are characterized by a signature 7-transmembrane domain motif. The encoded protein may modulate insulin secretion and increased protein expression is associated with type 2 diabetes. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2015]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO22259 | GPRC5B Knockout cell line (HeLa) | Human | GPRC5B | 1:3~1:6 | Negative | Online Inquiry |
KO22260 | GPRC5B Knockout cell line (HCT 116) | Human | GPRC5B | 1:2~1:4 | Negative | Online Inquiry |
KO22261 | GPRC5B Knockout cell line (HEK293) | Human | GPRC5B | 1:3~1:6 | Negative | Online Inquiry |
KO22262 | GPRC5B Knockout cell line (A549) | Human | GPRC5B | 1:3~1:4 | Negative | Online Inquiry |
GPRC5B Gene Knockout Cell Lines are advanced cellular models engineered to specifically disrupt the expression of the GPRC5B gene, which encodes a member of the class C G protein-coupled receptor family. These knockout cell lines serve as valuable tools for understanding the biological functions of GPRC5B as well as its role in various physiological and pathological processes, including cancer research, neuronal function, and immune response.
The primary function of the GPRC5B knockout cell lines relies on CRISPR/Cas9 gene-editing technology, which precisely creates deletions or insertions within the GPRC5B gene sequence, rendering it nonfunctional. This mechanism allows researchers to investigate the consequent phenotypic changes, elucidating the gene’s contribution to signaling pathways and cellular mechanisms. As a result, these cell lines unveil insights into how GPRC5B influences cellular behaviors such as proliferation, migration, and gene expression.
Scientifically, the development and application of GPRC5B knockout cell lines hold significant importance, particularly in translational research settings. With growing evidence linking GPRC5B dysregulation to various cancers and neurological disorders, utilizing these cell lines can aid in the identification of potential therapeutic targets and biomarkers. Their application extends to drug screening, functional assays, and the validation of novel hypotheses in cancer biology.
One of the unique advantages of using our GPRC5B gene knockout cell lines is their robust validation and characterisation. This ensures high specificity and reproducibility, distinguishing them from alternative models, such as wild-type or non-targeted knockdown cell lines which may yield ambiguous results due to residual gene function. Additionally, these cell lines can be customized for various applications, allowing researchers to select the model most suited to their specific investigation.
Given the complexities of gene interactions in human health and disease, our GPRC5B Gene Knockout Cell Lines provide invaluable resources that significantly enhance the depth of biological research. We are committed to delivering high-quality biological products backed by extensive expertise in the field, guaranteeing our customers reliable and innovative solutions for their scientific inquiries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.